GenMark
Roche Diagnostics Q1 Sales Climb 50 Percent
The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year.
360Dx Index Declines 2 Percent in March, Continuing Downward Slope
Of the 31 companies in the index, 11 firms saw their stock prices increase, while 20 saw their share prices decline.
In Brief This Week: Roche, GenMark, Ortho Clinical Diagnostics, Thermo Fisher Scientific, and More
News items for the in vitro diagnostics industry for the week of March 22, 2021.
Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.
Roche to Acquire GenMark Diagnostics for $1.8B
Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.